title: Stopping prednisone in kidney transplant recipients taking cyclosporine: safety conditions.
authors.affiliation: Nephrology Department, Hospital G.M.D. L'Esperança, Barcelona, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Lloveras
authors.forename: J
authors.initials: J
authors.lastname: Masramon
authors.forename: A
authors.initials: A
authors.lastname: Orfila
authors.forename: X
authors.initials: X
authors.lastname: Cuevas
authors.forename: J
authors.initials: J
authors.lastname: Aubia
mesh_terms: D000961:Antilymphocyte Serum / Q000627:therapeutic use; D003524:Cyclosporins / Q000097:blood / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006084:Graft Rejection; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D007959:Lymphocyte Culture Test, Mixed; D011241:Prednisone / Q000008:administration & dosage* / Q000627:therapeutic use
chemical_list: D000961:Antilymphocyte Serum; D003524:Cyclosporins; D011241:Prednisone